[go: up one dir, main page]

SE8003805L - En farmaceutisk beredning med forbettrade utlosningsegenskap - Google Patents

En farmaceutisk beredning med forbettrade utlosningsegenskap

Info

Publication number
SE8003805L
SE8003805L SE8003805A SE8003805A SE8003805L SE 8003805 L SE8003805 L SE 8003805L SE 8003805 A SE8003805 A SE 8003805A SE 8003805 A SE8003805 A SE 8003805A SE 8003805 L SE8003805 L SE 8003805L
Authority
SE
Sweden
Prior art keywords
pharmaceutical preparation
coating
emission property
improved emission
quaternary ammonium
Prior art date
Application number
SE8003805A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Inventor
C B Bogentoft
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20341009&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8003805(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Haessle Ab filed Critical Haessle Ab
Priority to SE8003805A priority Critical patent/SE8003805L/
Priority to ZA00813017A priority patent/ZA813017B/xx
Priority to PH25653A priority patent/PH16539A/en
Priority to EP81850087A priority patent/EP0040590A3/fr
Priority to PT73065A priority patent/PT73065B/pt
Priority to NO811721A priority patent/NO811721L/no
Priority to DK221281A priority patent/DK221281A/da
Priority to ES502345A priority patent/ES502345A0/es
Priority to GR64998A priority patent/GR75634B/el
Publication of SE8003805L publication Critical patent/SE8003805L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SE8003805A 1980-05-21 1980-05-21 En farmaceutisk beredning med forbettrade utlosningsegenskap SE8003805L (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE8003805A SE8003805L (sv) 1980-05-21 1980-05-21 En farmaceutisk beredning med forbettrade utlosningsegenskap
ZA00813017A ZA813017B (en) 1980-05-21 1981-05-06 A pharmaceutical preparation having improved release properties
PH25653A PH16539A (en) 1980-05-21 1981-05-19 Pharmaceutical preparation having improved properties
EP81850087A EP0040590A3 (fr) 1980-05-21 1981-05-19 Préparation pharmaceutique à propriétés de libération améliorées
PT73065A PT73065B (en) 1980-05-21 1981-05-20 Process for preparing pharmaceutical compositions having improved release properties
NO811721A NO811721L (no) 1980-05-21 1981-05-20 R. farmasoeytisk preparat med forbedrede frigjoeringsegenskape
DK221281A DK221281A (da) 1980-05-21 1981-05-20 Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forbedrede frigivelsesegenskaber
ES502345A ES502345A0 (es) 1980-05-21 1981-05-20 Procedimiento para obtener una preparacion farmaceutica que comprende un nucleo recubierto de polimero acrilico y poli- mero insoluble en agua.
GR64998A GR75634B (fr) 1980-05-21 1981-05-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8003805A SE8003805L (sv) 1980-05-21 1980-05-21 En farmaceutisk beredning med forbettrade utlosningsegenskap

Publications (1)

Publication Number Publication Date
SE8003805L true SE8003805L (sv) 1981-11-22

Family

ID=20341009

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8003805A SE8003805L (sv) 1980-05-21 1980-05-21 En farmaceutisk beredning med forbettrade utlosningsegenskap

Country Status (9)

Country Link
EP (1) EP0040590A3 (fr)
DK (1) DK221281A (fr)
ES (1) ES502345A0 (fr)
GR (1) GR75634B (fr)
NO (1) NO811721L (fr)
PH (1) PH16539A (fr)
PT (1) PT73065B (fr)
SE (1) SE8003805L (fr)
ZA (1) ZA813017B (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
WO1981002671A1 (fr) * 1980-03-20 1981-10-01 Ferring Farma Lab Composition pharmaceutique et methode de traitement de la colite ulcereuse et la maladie de crohn par voie orale
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DE3151196A1 (de) * 1981-12-23 1983-06-30 Kurt Heinz Prof. Dr. 7800 Freiburg Bauer Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
FR2554718B1 (fr) * 1983-11-14 1986-04-04 Ethypharm Sa Nouvelles formes galeniques du sulpiride utilisables par voie orale
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
SE460946B (sv) * 1987-03-16 1989-12-11 Lejus Medical Ab En multipel-unit-dos komposition av kinidinglukonat
DE3812799A1 (de) * 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
US5472710A (en) * 1988-04-16 1995-12-05 Schwarz Pharma Ag Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
DE69020758T2 (de) * 1989-03-10 1995-12-07 Yamanouchi Pharma Co Ltd Die Wirkstoffabgabe steuerndes Überzugsmaterial für lang wirksame Formulierungen.
US5372823A (en) * 1989-03-16 1994-12-13 Bristol-Myers Squibb Company Direct compression cholestyramine tablet and solvent-free coating thereof
PT93637A (pt) * 1989-04-20 1990-11-20 Procter & Gamble Metodo para o tratamento de desordens funcionais intestinais/colonicas, especialmente o sindrome de irritacao intestinal
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease
GB9015822D0 (en) * 1990-07-18 1990-09-05 Beecham Group Plc Compositions
GEP19971086B (en) * 1991-02-22 1997-12-02 Tillotts Pharma Ag Peroral Pharmaceutically Dispensed Form for Selective Introducing of the Medicine into the Intestine
WO1992016214A1 (fr) * 1991-03-15 1992-10-01 Norwich Eaton Pharmaceuticals Inc. Utilisation d'acide 5-aminosalicylique pour le traitement de colon irritable - type ou phase diarrheique (ibs-d)
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
DE29502547U1 (de) * 1995-02-16 1995-03-30 Röhm GmbH, 64293 Darmstadt Thermoplastisches Überzugs- und Bindemittel für Arzneiformen
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
CN1296417A (zh) 1998-02-10 2001-05-23 卫福有限公司 控释制剂
NZ513037A (en) 1999-01-29 2003-05-30 Disphar Internat B Coated sustained release pharmaceutical composition for the release of an agent in the gastrointestinal tract
IT1318376B1 (it) * 2000-03-07 2003-08-25 Pharmatec Internat S R L Forme solide orali a rilascio controllato contenenti mesalazina comeprincipio attivo.
CA2359812C (fr) 2000-11-20 2004-02-10 The Procter & Gamble Company Formes posologiques pharmaceutiques a couches multiples permettant de reduire l'impact des revetement fractures
AU2003269741A1 (en) * 2002-05-15 2003-12-02 Sun Pharmaceutical Industries Limited Coated sustained release tablets of a hygroscopic compound for once-a-day therapy
PE20040134A1 (es) 2002-07-25 2004-03-06 Pharmacia Corp Forma de dosificacion de una vez al dia de pramipexol
GB2430368B (en) 2004-03-30 2009-08-26 Ilypsa Inc Methods and compositions for treatment of ion imbalances
US8282960B2 (en) * 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
UA95993C2 (ru) * 2004-08-13 2011-09-26 Бёрингер Ингельхайм Интернациональ Гмбх Композиция пеллеты пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
US8889184B2 (en) * 2006-09-07 2014-11-18 Losan Pharma Gmbh Particulate form of a pharmaceutical composition which is easy to swallow
JP2011509265A (ja) * 2008-01-10 2011-03-24 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング 活性物質のパルス放出が強化された、コーティングされた医薬製剤もしくはニュートラシューティカル製剤
US20110070302A2 (en) * 2008-01-10 2011-03-24 Evonik Roehm Gmbh Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release
CA2739465C (fr) 2008-10-03 2017-01-31 Dr. Falk Pharma Gmbh Compositions et procedes permettant de traiter les maladies intestinales a l'aide de mesalamine granulee
CA2936748C (fr) 2014-10-31 2017-08-08 Purdue Pharma Methodes et compositions destinees au traitement du trouble de deficit d'attention
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
FR3102931B1 (fr) 2019-11-13 2021-12-24 Ethypharm Sa Procédé de fabrication d’une composition pharmaceutique à administration orale et à délivrance colonique
EP4057998A1 (fr) 2019-11-13 2022-09-21 Ethypharm Procédé de fabrication d'une composition pharmaceutique à administration orale et à délivrance colonique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1204363B (de) * 1963-09-10 1965-11-04 Hoffmann La Roche Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt
DE2150539A1 (de) * 1970-06-11 1973-04-19 Richardson Merrell Inc Mittel gegen den befall von pferden durch dassel-larven
DE2340060A1 (de) * 1973-08-08 1975-02-20 Scherer Gmbh R P Magensaftresistente gelatinekapseln und verfahren zu deren herstellung

Also Published As

Publication number Publication date
DK221281A (da) 1981-11-22
PT73065B (en) 1983-02-08
NO811721L (no) 1981-11-23
PT73065A (en) 1981-06-01
GR75634B (fr) 1984-08-01
EP0040590A3 (fr) 1983-01-12
EP0040590A2 (fr) 1981-11-25
PH16539A (en) 1983-11-10
ES8301630A1 (es) 1982-12-16
ES502345A0 (es) 1982-12-16
ZA813017B (en) 1982-05-26

Similar Documents

Publication Publication Date Title
SE8003805L (sv) En farmaceutisk beredning med forbettrade utlosningsegenskap
DZ593A1 (fr) Résinate d'un acide carboxylique substitué, procédé pour sa préparation, son utilisation et compositions pharmaceutiques le contenant.
FR2325663A1 (fr) Procede de preparation d'emulsions aqueuses stables de polymeres et copolymere d'addition
FR2321892A1 (fr) Preparations pharmaceutiques pour l'administration orale renfermant un ester-17b de nandrolone et nouveaux esters-17b de nandrolone
BE863761A (fr) Preparation d'emulsion de copolymeres d'acide carboxylique-ethylenique et l'acrylate de methyle
BE891609A (fr) Preparation d'acides carboxyliques
FR2448535A1 (fr) Nouveaux derives tricycliques et leurs sels, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
JPS56154417A (en) Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it
FR2472561B1 (fr) Derives de l'acide 4-guanidinomethylcyclohexane carboxylique, leur procede de preparation et leur application en therapeutique
FR2490491B1 (fr) Composition pharmaceutique analgesique contenant comme ingredient actif l'acide 3-amino-2-hydroxy-4 phenylbutanoique et ses derives et application
BE891610A (fr) Preparation d'anhydrides d'acides carboxyliques
BE861888A (fr) Compositions contenant un derive de l'acide salicyclique et applications a titre de medicament
FR2343730A1 (fr) Derives d'acide amidinoformique ou d'acide amidinosulfinique, leur preparation et compositions pharmaceutiques les contenant
PT71495A (fr) Procede d'obtention d'extraits de lierre grimpant et de compositions pharmaceutiques qui en contiennent
PT88634A (pt) A process for the preparation of catechol carboxylic acid derivatives and of pharmaceutical compositions containing the same
BE878020A (fr) Derives n-substitues de l'acide aziridine-2-carboxylique immunostimulateurs, procedes de preparation et compositions pharmaceutiques les contenant
FR2330395A1 (fr) Ester isobutylique de l'acide 2,6-dimethyl-3-methoxycarbonyl-4-(2'nitrophenyl)-1,4-dihydropyridine-5-carboxylique, son procede de preparation et medicament a usage coronarien le contenant
BE891611A (fr) Preparation d'anhydrides d'acides carboxyliques
FR2353556A1 (fr) Derives de l'acide clavulanique, leur procede de preparation et leur application en therapeutique
FR2335222A1 (fr) Derives etherifies de l'acide clavulanique, leur preparation et compositions therapeutiques en contenant
BE878836A (fr) Derives d'acide hydroxamique, leur procede de preparation et medicament les contenant
FR2315910A1 (fr) Compositions pharmaceutiques contenant de la " debrycine " heterocolloidale et procede pour leur preparation
MY8600679A (en) New 5 (6)-(2-amino-thiazoloyl) benzimidazole-2-carbamic acid esters and salts thereof their preparation and use and pharmaceutical formulation containing them
BE873890A (fr) Derives d'acide naphtyl-1 acetique, leur procede de preparation et leur application therapeutique
BE893323A (fr) Preparation d'anhydrides d'acides carboxyliques

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8003805-2